Handling Editor: Derek Walsh
ABSTRACT
Human cytomegalovirus (HCMV) establishes life-long latent infection in hematopoietic progenitor cells and circulating monocytes in infected individuals. Myeloid differentiation coupled with immune dysregulation leads to viral reactivation, which can cause severe disease and mortality. Reactivation of latent virus requires chromatin reorganization and the removal of transcriptional repressors in exchange for transcriptional activators. While some factors involved in these processes are identified, a complete characterization of the viral and cellular factors involved in their upstream regulation remains elusive. Herein, we show the HCMV-encoded G protein-coupled receptor (GPCR), UL33, is expressed during latency. Although this viral GPCR is not required to maintain latent infection, our data reveal UL33-mediated signaling is important for efficient viral reactivation. Additionally, UL33 signaling induces cellular cyclic AMP response element binding protein (CREB1, referred to here as CREB) phosphorylation, a transcription factor that promotes reactivation when recruited to the major immediate early (MIE) enhancer/promoter. Finally, targeted pharmacological inhibition of CREB activity reverses the reactivation phenotype of the UL33 signaling-deficient mutant. In sum, our data reveal UL33-mediated signaling functions to activate CREB, resulting in successful viral reactivation.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: B.A.K., C.M.O.; Methodology: B.A.K., A.B.W., C.M.O.; Validation: B.A.K., A.B.W.; Formal analysis: B.A.K.; Investigation: B.A.K., A.B.W.; Resources: B.A.K., A.B.W., A.L.D.; Writing - original draft: B.A.K.; Writing - review & editing: B.A.K., A.B.W., A.L.D., C.M.O.; Visualization: B.A.K., C.M.O.; Supervision: C.M.O.; Project administration: C.M.O.; Funding acquisition: C.M.O., A.L.D.
Funding
This work was supported by the Cleveland Clinic (to C.O.), National Institutes of Health (AI153348 to C.O.), and the American Heart Association and the Hablitzel Family (20PRE35080060 to A.D.). Deposited in PMC for release after 12 months.
Supplementary information
Supplementary information available online at https://jcs.biologists.org/lookup/doi/10.1242/jcs.254268.supplemental
- Received September 15, 2020.
- Accepted November 2, 2020.
- © 2021. Published by The Company of Biologists Ltd
Log in using your username and password
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00 .
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.